Literature DB >> 18672401

Testing the mettle of PBT2 for Alzheimer's disease.

Norman R Relkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18672401     DOI： 10.1016/S1474-4422(08)70168-6

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  3 in total

Review 1.  Regulation of β cleavage of amyloid precursor protein.

Authors:  Jun-Feng Wang; Rui Lu; Yi-Zheng Wang
Journal:  Neurosci Bull       Date:  2010-10       Impact factor: 5.203

Review 2.  Challenges associated with metal chelation therapy in Alzheimer's disease.

Authors:  Muralidhar L Hegde; P Bharathi; Anitha Suram; Chitra Venugopal; Ramya Jagannathan; Pankaj Poddar; Pullabhatla Srinivas; Kumar Sambamurti; Kosagisharaf Jagannatha Rao; Janez Scancar; Luigi Messori; Luigi Zecca; Paolo Zatta
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 3.  The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease.

Authors:  Simon C Drew
Journal:  Front Neurosci       Date:  2017-06-02       Impact factor: 4.677
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.